Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in TB/HIV coinfected patients recruited in two phase III clinical trials (61 patients in TB-HAART and 222 patients in RAFA study) were described using nonlinear mixed-effects modelling. Concentration-time data for rifampicin...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Clinical Pharmacology
2018
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
- In vivo Pharmacodynamic and Pharmacokinetic Interactions of Hibiscus sabdariffa Calyces Extracts with Simvastatin
- Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Investigating the effects of treatment in HIV disease models
- The determination and validation of population pharmacokinetic parameters of phenytoin in adult epileptic patients in the Western Cape using nonlinear mixed-effects modelling
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling